Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
TREATMENT OF RESISTANT FIBROMYALGIA
Autore:
WILKE WS;
Indirizzi:
CLEVELAND CLIN FDN,DEPT RHEUMAT & IMMUNOL DIS,9500 EUCLID AVE CLEVELAND OH 44195
Titolo Testata:
Rheumatic diseases clinics of North America
fascicolo: 1, volume: 21, anno: 1995,
pagine: 247 - 260
SICI:
0889-857X(1995)21:1<247:TORF>2.0.ZU;2-2
Fonte:
ISI
Lingua:
ENG
Soggetto:
CHRONIC FATIGUE SYNDROME; PRESSURE PAIN THRESHOLD; DOUBLE-BLIND CROSSOVER; PRIMARY FIBROSITIS; CONTROLLED TRIAL; S-ADENOSYLMETHIONINE; MYOFASCIAL PAIN; PLACEBO; AMITRIPTYLINE; IBUPROFEN;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Citazioni:
75
Recensione:
Indirizzi per estratti:
Citazione:
W.S. Wilke, "TREATMENT OF RESISTANT FIBROMYALGIA", Rheumatic diseases clinics of North America, 21(1), 1995, pp. 247-260

Abstract

Long-term outcome for the majority of patients with fibromyalgia is sufficiently disappointing so that most patients can be considered to have ''resistant'' disease. Among published treatments, education, active exercise, and nighttime antidepressant medications perform best. Patients eligible for treatment include those with primarily regional symptoms, wide-spread pain without 11 or fewer tender points, or ''typical patients'' as defined by the American College of Rheumatology criteria. Factors important in the process of prognosis of the syndrome should be identified and addressed in an integrated therapeutic program in order to positively influence outcome.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/09/20 alle ore 12:00:17